Diana Hausman

2013 - Oncothyreon

In 2013, Diana Hausman earned a total compensation of $641.7K as Chief Medical Officer at Oncothyreon, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$96,787
Option Awards$189,000
Salary$345,050
Other$10,843
Total$641,680

Hausman received $345.1K in salary, accounting for 54% of the total pay in 2013.

Hausman also received $96.8K in non-equity incentive plan, $189K in option awards and $10.8K in other compensation.

Rankings

In 2013, Diana Hausman's compensation ranked 8,478th out of 12,286 executives tracked by ExecPay. In other words, Hausman earned more than 31.0% of executives.

ClassificationRankingPercentile
All
8,478
out of 12,286
31st
Division
Services
1,357
out of 1,938
30th
Major group
Engineering, Accounting, Research, Management, And Related Services
115
out of 184
38th
Industry group
Research, Development, And Testing Services
37
out of 63
41st
Industry
Commercial Physical and Biological Research
37
out of 55
33rd
Source: SEC filing on May 6, 2016.

Hausman's colleagues

We found four more compensation records of executives who worked with Diana Hausman at Oncothyreon in 2013.

2013

Robert Kirkman

Oncothyreon

Chief Executive Officer

2013

Gary Christianson

Oncothyreon

Chief Operating Officer

2013

Julia Eastland

Oncothyreon

Chief Financial Officer

2013

Scott Peterson

Oncothyreon

Chief Scientific Officer

News

You may also like